Rejected from Microbiome? Where to Submit Next

The useful question is not "which microbiome journal is easier?" It is "what did Microbiome not believe about this manuscript?"

If the editor did not believe the paper moved beyond descriptive profiling, the next journal should probably be broader-validity, specialist, or dataset-friendly. If reviewers believed the topic mattered but the functional bridge was thin, the manuscript needs repair before resubmission. If reviewers questioned contamination controls, sample metadata, batch effects, compositional statistics, code availability, raw-data access, functional validation, host relevance, environmental interpretation, or causality, those problems travel with the paper.

Use the decision letter to classify the failure:

Microbiome is broad by habitat but not loose by evidence logic. A manuscript can involve a microbiome and still fail if it does not explain a structure-function relationship, host interaction, ecological consequence, method advance, or substantial field contribution.

That makes the rejection diagnostically useful. It often means one of three things:

• The dataset is interesting but still descriptive. The paper may show diversity shifts, differential abundance, beta-diversity separation, or metagenomic pathway prediction without enough functional interpretation.
• The claim outruns the design. The manuscript may describe causality, disease relevance, treatment response, soil function, plant interaction, or host mechanism even though the controls and metadata only support association.
• The evidence trail is hard to audit. Microbiome's own guidance makes data, metadata, and analytical scripts central. If reviewers cannot inspect the raw-data and analysis path, the science looks less reliable than it may be.

This is why the next submission should be routed by manuscript phenotype, not by impact-factor adjacency.

This page was researched from the current Springer Nature and BMC Microbiome journal pages, aims and scope, submission guidelines, methodology/research guidance, fees-and-funding page, existing Manusights Microbiome pages, and adjacent microbiome and microbiology journal positioning. The official materials consistently frame Microbiome around microbiome structure, function, host or community interaction, meta-omics, bioinformatics, and reproducible data access.

In our analysis of the post-rejection routing job, the non-obvious question is not whether ISME Journal or Gut Microbes is "next." It is which manuscript component created the rejection signal: study system, sampling frame, controls, contamination handling, metadata, raw-data access, analytical scripts, first figure, functional validation, cover letter, or limitations.

The specific rejection patterns below are written as a diagnostic, not as a generic journal list. We see authors lose time when they interpret a Microbiome rejection as a prestige problem, but the paper actually has a function, reproducibility, controls, or audience problem. In practice, the best next journal is the one where the manuscript's evidence can support its claim without forcing a broad Microbiome-level structure-function story that the data cannot carry.

Rebuild for Microbiome only when the manuscript still has a strong microbiome-level claim and the rejection exposed a repairable weakness. This is most plausible after a detailed review, a revision decision, or a desk rejection where the science was relevant but the function, controls, or data-readiness signals were not visible enough.

Good reasons to rebuild:

• The paper shows a structure-function relationship, host interaction, ecological mechanism, method advance, or substantial microbiome insight that the current draft hid.
• The rejection letter questioned framing, data availability, metadata, analytical scripts, contamination controls, statistical choices, or fit argument rather than the core study.
• Missing accession details, code, metadata, validation, covariate handling, negative controls, functional assays, or figure-order repairs are achievable.
• The strongest microbiome consequence was buried in supplementary tables or the discussion instead of visible in the title, abstract, first figure, and cover letter.

Bad reasons to rebuild:

• You only want to stay near a top microbiome-specific prestige signal.
• The paper is a descriptive 16S, metagenomic, or metabolomic survey with no functional payoff.
• The result is clinically interesting but only loosely microbiome-specific.
• The key limitation requires a new cohort, new time series, new perturbation experiment, new validation system, or different study design.

If you rebuild, make the correction visible early. A new cover letter cannot rescue a manuscript whose title, abstract, first figure, and data statement still read like the wrong journal.

ISME Journal can be the cleaner next route when the manuscript is ecology-forward. If the paper's strength is community assembly, ecosystem process, microbial interaction, environmental gradient, plant or soil system, or ecological theory, the next editor needs that logic before any broad microbiome-brand argument.

Gut Microbes or a GI journal can be better when the story is host-microbe and disease-facing. A gut, diet, inflammatory bowel disease, colorectal cancer, antibiotic, immune, metabolism, or treatment-response paper may convert better when the audience already cares about the host context.

mSystems or mSphere can be better when the manuscript is systems microbiology, bioinformatics, omics integration, or broad microbial science but does not need Microbiome's exact scope. These routes can be more honest for papers where the method or microbial system is the protagonist.

Choose these routes when the manuscript can answer:

• What microbiome function, interaction, ecology, host consequence, or method does the result explain?
• Which controls, metadata, raw data, code, or validation support that explanation?
• Is the strongest reader a microbiome generalist, microbial ecologist, clinician, animal scientist, plant scientist, environmental scientist, or methods specialist?
• Does the manuscript make a causal or functional claim it can actually defend?

If the answer is mostly "the community composition changed," repair the interpretation or choose a more dataset-appropriate venue.

Many Microbiome rejections are good papers in the wrong lane.

Move toward Environmental Microbiome when the manuscript's value is strongest for environmental systems, built environments, soil, water, agriculture, biogeochemistry, or ecological monitoring. Move toward Animal Microbiome when the work is animal-host, livestock, veterinary, companion-animal, or production-system focused. Move toward plant, soil, food, oral, skin, infectious-disease, or GI journals when the domain audience is more important than a broad microbiome audience.

The rewrite should reduce field-wide overclaiming. Do not pretend every microbiome result needs a flagship microbiome-specific venue. Make the action specific: which reader can use the community shift, function, model, dataset, method, or biological interpretation?

Move toward bioinformatics or methods journals when the strongest contribution is pipeline, benchmark, software, database, or analytical framework. Microbiome considers methods and meta-omics work, but the method still needs clear value for microbiome research rather than a narrow technical tweak.

In our pre-submission and post-decision review work with manuscripts aimed at Microbiome, the highest-value repairs are usually not language edits. They are function, control, and reproducibility decisions tied to concrete components: title, abstract, first figure, sampling frame, metadata table, contamination controls, negative controls, sequencing or omics pipeline, statistical model, raw-data accession, analytical scripts, cover letter, and limitations.

Three specific rejection patterns are especially common.

The composition-without-function gap. The manuscript contains sequencing depth, diversity metrics, ordination plots, differential abundance, or predicted pathways, but it does not show what changed biologically. Editors can usually see this from the abstract and first figure. The repair is not another taxonomy plot. The repair is functional validation, ecological consequence, host-response evidence, metabolite logic, experimental perturbation, or a narrower claim.

The data-trail gap. The paper may be scientifically promising, but reviewers cannot easily audit the raw data, metadata, code, scripts, contamination handling, or statistical assumptions. Microbiome's guidance makes reproducibility part of the submission logic, not later cleanup. The repair is to make the data trail inspectable before another editor asks reviewers to invest time.

The wrong-audience gap. The strongest readers for the paper are not necessarily broad Microbiome readers. A soil community paper may be better as soil ecology. A gut paper may be better as GI or host-microbe translation. An animal-production study may be better in Animal Microbiome or a veterinary journal. A software paper may be better as methods. These manuscripts often improve after rejection because the next submission finally names the correct audience and writes for that audience.

For Microbiome specifically, we check whether the title, abstract, first figure, metadata table, data statement, and cover letter all make the same promise. If the title promises a structure-function advance but the data only support association, the paper should either add evidence or move to a venue that values the current dataset. If the data support a specific habitat or host rather than broad microbiome understanding, a specialist journal is often stronger than another broad target.

The practical lesson is direct: after Microbiome rejection, the manuscript should either become a clearer function-and-reproducibility microbiome paper or a more honest paper for the audience that can use the evidence you actually have. The worst option is a cosmetic resubmission that preserves the same unsupported causal or functional claim.